DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour

Authors

  • Mona-Elisabeth Revheim Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
  • Knut Håkon Hole Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Radiology, Oslo University Hospital, Oslo, Norway
  • Øyvind Sverre Bruland nstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
  • Hans Kristian Haugland Division of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
  • Kirsten Sundby Hall Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
  • Therese Seierstad Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Faculty of Health Sciences, Buskerud University College, Drammen, Norway

DOI:

https://doi.org/10.3109/0284186X.2010.516273

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-01-01

How to Cite

Revheim, M.-E., Håkon Hole, K., Sverre Bruland, Øyvind, Kristian Haugland, H., Sundby Hall, K., & Seierstad, T. (2011). DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour. Acta Oncologica, 50(1), 148–150. https://doi.org/10.3109/0284186X.2010.516273

Issue

Vol. 50 No. 1 (2011): Acta Oncologica

Section

Articles